Dr. Kalyanam Nagabhushanam, President (R&D), Sabinsa Corporation presented, at the invitation of FDA, a seminar on December 10, 2020 to a group of US FDA scientists as part of the CDER Botanical Drug Seminar Series (BDSS).
- Details
- Press Release
- Details
- Press Release
Sabinsa ends the year with more good news about achievements. The Confederation of Indian Industry (CII) recognized the Sami-Sabinsa Group with two awards for IP property, and Sami-Sabinsa Founder and Chairman, Dr. Muhammed Majeed, was honored by the Indian Association for the Study of Traditional Asian Medicine (IASTAM). Additionally, the company has been granted five new U.S. patents, including strengthening IP protection on its flag-ship probiotic, LactoSpore® with new applications, and additional patents for novel compositions.
- Details
- Press Release
Sabinsa’s proprietary formulation Macumax® was shown to have vision health benefits in a clinical trial on subjects diagnosed with age-related macular degeneration (AMD). The study An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration authored by Muhammed Majeed, Shaheen Majeed and Kalyanam Nagabhushanam, was published in the Journal of Medicinal Food (ahead of print doi.org/10.1089/jmf.2020.0097).
- Details
- Press Release
Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group was honored with a lifetime achievement award in recognition of his exemplary services in the nutraceuticals and cosmeceuticals industry by ASSOCHAM (The Associated Chambers of Commerce and Industry of India). The award was presented as part of Ayush Mela, one of India’s largest exhibition and conference events related to Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy (AYUSH).
- Details
- Press Release
Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group has recently published the fourth book in a series on derivatives of Boswellia serrata.